| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Acting Chief Business Officer
1 company
Savill Corrine is a Chief Business Officer at Cullinan Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Business Officer | Sale+OE | 40,000 | $16.18 | $647,200.00 | -19.4% | +60.5% | -39.7% | |
| Jan 29, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Business Officer | Sale+OE | 40,000 | $14.09 | $563,600.00 | -19.4% | +84.6% | -28.9% | |
| Jan 23, 2024 | CGEM Cullinan Therapeutics, Inc. | Chief Business Officer | Sale+OE | 40,000 | $12.31 | $492,508.48 | -7.4% | +25.0% | -15.9% | |
| Jul 19, 2022 | CGEM Cullinan Therapeutics, Inc. | Acting Chief Business Officer | Sell | 20,000 | $15.18 | $303,593.28 | -6.0% | -18.0% | -27.7% | |
| Jul 11, 2022 | CGEM Cullinan Therapeutics, Inc. | Acting Chief Business Officer | Sell | 40,000 | $13.33 | $533,304.00 | -10.5% | -5.7% | -25.1% |